e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Systemic biomarkers for airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant protein expression at various COPD Gold stages
S. Seehase, H. Watz, C. Kugler, E. Vollmer, T. Goldmann (Borstel, Grosshansdorf, Germany)
Source:
International Congress 2014 – Systemic biomarkers for airway diseases
Session:
Systemic biomarkers for airway diseases
Session type:
Thematic Poster Session
Number:
3994
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Seehase, H. Watz, C. Kugler, E. Vollmer, T. Goldmann (Borstel, Grosshansdorf, Germany). Surfactant protein expression at various COPD Gold stages. Eur Respir J 2014; 44: Suppl. 58, 3994
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Michael Klein (München, Germany) - 08.09.2014 12:06
hello, excellent poster! is it possible to receive the poster?thank you, best wishes,michael klein
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Risk factors associated with the development of interstitial lung abnormalities
Related content which might interest you:
The relationship between surfactant protein D and respiratory functions in COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Pharmacological treatment of COPD in the on-sint cohort
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Evaluation of the use of CAT in COPD. Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Is early diagnosis of COPD possible? Preliminary results of early COPD study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
COPD severity related to extended measurements of lung volume, diffusion, and resistance
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Asthma control is not related to large airways function
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Prevalence of small airway dysfunction among GOLD stages in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Small airways obstruction and asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Monitoring of airway resistance (Raw) in exacerbation of asthma
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept